{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:19:40Z","timestamp":1778807980239,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.semarthrit.2023.152328","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T03:42:36Z","timestamp":1700624556000},"page":"152328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S","title":["The role of Siglec-G on B cells in autoimmune disease and leukemia"],"prefix":"10.1016","volume":"64","author":[{"given":"Bettina","family":"R\u00f6der","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Nitschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2023.152328_bib0001","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.3389\/fimmu.2018.02820","article-title":"B cell siglecs-news on signaling and its interplay with ligand binding","volume":"9","author":"Meyer","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2023.152328_bib0002","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni1480","article-title":"Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population","volume":"8","author":"Hoffmann","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.semarthrit.2023.152328_bib0003","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4049\/jimmunol.1403139","article-title":"Siglec-G deficiency leads to autoimmunity in aging C57BL\/6 mice","volume":"195","author":"M\u00fcller","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2023.152328_bib0004","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.4049\/jimmunol.1303367","article-title":"Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL\/lpr mice","volume":"192","author":"B\u00f6kers","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2023.152328_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaut.2013.01.008","article-title":"Genetic susceptibility to SLE: recent progress from GWAS","volume":"41","author":"Cui","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2023.152328_bib0006","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.4049\/jimmunol.0902711","article-title":"CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity","volume":"184","author":"Jellusova","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2023.152328_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1095830","article-title":"Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus","volume":"14","author":"Korn","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2023.152328_bib0008","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.it.2013.07.002","article-title":"B cell receptor signaling in chronic lymphocytic leukemia","volume":"34","author":"Burger","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.semarthrit.2023.152328_bib0009","doi-asserted-by":"crossref","first-page":"e56420","DOI":"10.15252\/embr.202256420","article-title":"The inhibitory receptor Siglec-G controls the severity of chronic lymphocytic leukemia","author":"R\u00f6der","year":"2023","journal-title":"EMBO Rep"},{"key":"10.1016\/j.semarthrit.2023.152328_bib0010","doi-asserted-by":"crossref","first-page":"10588","DOI":"10.1021\/acs.jmedchem.2c00765","article-title":"Targeting human CD22\/Siglec-2 with dimeric sialosides as novel oligosaccharide mimetics","volume":"65","author":"Prescher","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.semarthrit.2023.152328_bib0011","article-title":"Efficacy and safety of epratuzumab in patients with moderate-to-severe systemic lupus erythematosus: results from two phase 3 randomized, placebo-controlled trials [abstract]","volume":"67","author":"Clowse","year":"2015","journal-title":"Arthritis Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223001701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223001701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:12:25Z","timestamp":1758733945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017223001701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":11,"alternative-id":["S0049017223001701"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152328","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of Siglec-G on B cells in autoimmune disease and leukemia","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152328"}}